Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy.
Fabbri C, Jaboli MF, Giovanelli S, Azzaroli F, Pezzoli A, Accogli E, Liva S, Nigro G, Miracolo A, Festi D, Colecchia A, Montagnani M, Roda E, Mazzella G. Fabbri C, et al. Among authors: montagnani m. World J Gastroenterol. 2003 Jul;9(7):1487-90. doi: 10.3748/wjg.v9.i7.1487. World J Gastroenterol. 2003. PMID: 12854147 Free PMC article. Clinical Trial.
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial.
Jaboli MF, Fabbri C, Liva S, Azzaroli F, Nigro G, Giovanelli S, Ferrara F, Miracolo A, Marchetto S, Montagnani M, Colecchia A, Festi D, Reggiani LB, Roda E, Mazzella G. Jaboli MF, et al. Among authors: montagnani m. World J Gastroenterol. 2003 Jul;9(7):1491-5. doi: 10.3748/wjg.v9.i7.1491. World J Gastroenterol. 2003. PMID: 12854148 Free PMC article. Clinical Trial.
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis.
Azzaroli F, Accogli E, Nigro G, Trere D, Giovanelli S, Miracolo A, Lodato F, Montagnani M, Tamé M, Colecchia A, Mwangemi C, Festi D, Roda E, Derenzini M, Mazzella G. Azzaroli F, et al. Among authors: montagnani m. World J Gastroenterol. 2004 Nov 1;10(21):3099-102. doi: 10.3748/wjg.v10.i21.3099. World J Gastroenterol. 2004. PMID: 15457551 Free PMC article. Clinical Trial.
Efficacy of ursodeoxycholic acid in association with alpha-interferon for chronic hepatitis C in alpha-interferon non-responder patients.
Fabbri C, Marchetto S, Pezzoli A, Accogli E, Fusaroli P, Azzaroli F, Jaboli MF, Mazzeo C, Montagnani M, Festi D, Roda E, Mazzella G. Fabbri C, et al. Among authors: montagnani m. Eur J Gastroenterol Hepatol. 2000 May;12(5):511-5. doi: 10.1097/00042737-200012050-00006. Eur J Gastroenterol Hepatol. 2000. PMID: 10833093 Clinical Trial.
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study.
Lodato F, Azzaroli F, Brillanti S, Colecchia A, Tamé MR, Montagnani M, Muratori R, Giovanelli S, Feletti V, Bacchi Reggiani ML, Roda E, Mazzella G. Lodato F, et al. Among authors: montagnani m. J Viral Hepat. 2005 Sep;12(5):536-42. doi: 10.1111/j.1365-2893.2005.00638.x. J Viral Hepat. 2005. PMID: 16108771 Clinical Trial.
Lamivudine treatment for severe acute HBV hepatitis.
Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Alessandrelli F, Mazzella G. Lisotti A, et al. Among authors: montagnani m. Int J Med Sci. 2008;5(6):309-12. doi: 10.7150/ijms.5.309. Epub 2008 Oct 23. Int J Med Sci. 2008. PMID: 18974858 Free PMC article.
235 results